Abstract
Background: Metacognitive difficulties are frequent among youth with a psychiatric disorder. The present study evaluates the effectiveness of a dramatic writing workshop on the metacognition of youth aged from 14 to 25 years, the majority presenting a stabilized psychiatric disorder.
Methods: Twenty-four youth were recruited for the study, 12 youth who received the workshop and 12 who did not. Among each group of 12 eligible participants, 10 presented with a stabilized psychiatric disorder and two did not. Metacognition, social cognition, psychological and social functioning measures as well as questionnaires about objectives and appreciation regarding the workshop were used.
Results: Analyses revealed no differences between groups after the workshop in regard to youth’s metacognition, social cognition, nor psychological and social functioning. On the other hand, youth who participated in the workshop appreciated their experience, and their psychological and social functioning didn’t deteriorate.
Conclusions: Study results suggest that the duration of the workshop and the number of sessions should be extended.
Keywords: Metacognition, psychiatric outpatient, social cognition, writing workshop, young adult.
Adolescent Psychiatry
Title:Evaluation of a Dramatic Writing Workshop in Youth With or Without Psychiatric Disorders
Volume: 5 Issue: 4
Author(s): Elyse Porter-Vignola, Isabelle Daigneault, Patricia Garel and Serge Lecours
Affiliation:
Keywords: Metacognition, psychiatric outpatient, social cognition, writing workshop, young adult.
Abstract: Background: Metacognitive difficulties are frequent among youth with a psychiatric disorder. The present study evaluates the effectiveness of a dramatic writing workshop on the metacognition of youth aged from 14 to 25 years, the majority presenting a stabilized psychiatric disorder.
Methods: Twenty-four youth were recruited for the study, 12 youth who received the workshop and 12 who did not. Among each group of 12 eligible participants, 10 presented with a stabilized psychiatric disorder and two did not. Metacognition, social cognition, psychological and social functioning measures as well as questionnaires about objectives and appreciation regarding the workshop were used.
Results: Analyses revealed no differences between groups after the workshop in regard to youth’s metacognition, social cognition, nor psychological and social functioning. On the other hand, youth who participated in the workshop appreciated their experience, and their psychological and social functioning didn’t deteriorate.
Conclusions: Study results suggest that the duration of the workshop and the number of sessions should be extended.
Export Options
About this article
Cite this article as:
Porter-Vignola Elyse, Daigneault Isabelle, Garel Patricia and Lecours Serge, Evaluation of a Dramatic Writing Workshop in Youth With or Without Psychiatric Disorders, Adolescent Psychiatry 2015; 5(4) . https://dx.doi.org/10.2174/2210676606666160502125800
DOI https://dx.doi.org/10.2174/2210676606666160502125800 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial
Current Alzheimer Research Oxidative Stress and Psychological Disorders
Current Neuropharmacology Functional Networks in Diabetes-Progression by Comparison of Gene Expression in Three Tissues of Goto-Kakizaki Rats
Current Bioinformatics Increased Mitochondrial DNA Deletions in Substantia Nigra Dopamine Neurons of the Aged Rat
Current Aging Science Recent Progress in BINOL Mediated Asymmetric Reactions
Mini-Reviews in Organic Chemistry Recent Advances in Epilepsy
Current Neuropharmacology Monocarboxylate Transporter 1 in Brain Diseases and Cancers
Current Drug Metabolism The Therapeutic Potential of Adenosine Triphosphate as an Immune Modulator in the Treatment of HIV/AIDS: A Combination Approach with HAART
Current HIV Research Functional Central Nicotinic Acetylcholine Receptor Antagonism by Systemic Administration of Tinuvin 770 (BTMPS)
Current Alzheimer Research Acknowledgements
Central Nervous System Agents in Medicinal Chemistry Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery Density Functional Theory, Docking, Bioisosteric Replacement, Pharmacophore Perception, Physical Chemical Analyses of the Interactions of Novel PIM-1 Inhibitors with Suitable Pharmacokinetic Properties for Cancer Treatment
Current Physical Chemistry Starting Point, Duration of Acquisition and Averaged of Time Series Over Subjects: Issues Related to the Reliability and Accuracy of the Constructed Group Bayesian Network for Resting-state fMRI Studies
Neuroscience and Biomedical Engineering (Discontinued) The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Current Drug Targets for Modulating Alzheimer's Amyloid Precursor Protein: Role of Specific Micro-RNA Species
Current Medicinal Chemistry The Role of Nuclear Receptor PPARα in the Sleep-wake Cycle Modulation. A Tentative Approach for Treatment of Sleep Disorders
Current Drug Delivery Peptide-based Vaccines in the Treatment of Specific Allergy
Current Drug Targets - Inflammation & Allergy The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
Current Drug Metabolism Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders
Current Neuropharmacology A Possible Case of Bipolar Disorder Unmasked by Dextromethorphan in a 16-year-old Adolescent
Adolescent Psychiatry